FDA Greenlights Regeneron's Antibody Cocktail for Ebola The U.S. Food and Drug Administration (FDA) has approved the antibody cocktail Inmazeb for the treatment of the Ebola Virus in adult and ...
Alkermes Reigns in with New Schizophrenia Drug 🧠💸 Alkermes plc. announced positive voting outcomes from the joint meeting of the Drug Safety and Risk Management and the Psychopharmacologi...
Moleculin's Drug Candidate Lowers Size of a Rare Brain Tumor Moleculin Biotech, Inc., a clinical-stage pharmaceutical firm with a broad portfolio of drug candidates aimed at major unmet needs in the...
Alkermes Reigns in with New Schizophrenia Drug 🧠💸 Alkermes plc. announced positive voting outcomes from the joint meeting of the Drug Safety and Risk Management and the Psychopharmacologi...
Amgen's KRAS Inhibitor Reduces Non-Small Cell Lung Cancer in a Phase I Clinical Trial Amgen is pulling the curtain on full data after releasing small snippets about its keenly watched KRAS inhibitor. The drug, tagged Sotora...
Chi Med Submits New Drug Application for Surufatinib to Treat Pancreatic Cancer Chinese biotech company Hutchison China MediTech, popularly known as Chi-Med, on Thursday announced that its Second NDA for Surufatinib f...
Aug 27 2 min Russian Roulette: A Plasma Treatment Without Efficacy is Playing Politics On August 23, 2020, The President of the United States and FDA announced an 'emergency authorization' of a drug that will be used as a tr...
Aug 14 3 min Living with SARS The Covid-19 pandemic has shown us that the world is never, at any time, safe. And thanks to the outbreak, scientists around the world ha...
Jun 12 4 min Insulin Drug Prices Turns Lethal for a Patient Rationing to Pay Rent Over the past several years there have been many horror stories about the USA healthcare system. Everything from the rising cost of prem...
Oct 5 1 min Genentech Buys Vaccibody's Investigational Drug for $200 Million Norwegian Biotech Company Vaccibody has signed an exclusive worldwide license and collaboration deal worth $200 million with Roche’s Gene...
Oct 3 2 min Mesoblast Shares Drop as FDA Rejects Remestemcel-L for Graft Versus Host Treatment Mesoblast a biotechnology company investigating how to use stem cells for therapeutics, announced its flagship treatment, remestemcel-L, ...
Oct 2 2 min Orgenesis Pumps in $15 Million For Koligo's Cell Therapy Assets Orgenesis Inc., a global biotech company, working to unravel the full potential of cell and gene therapies, and Koligo Therapeutics, Inc....
Sep 28 2 min Swedish Biotech Believes Second Time is the Charm for Rabeximod Cyxone, a small biotech company from Sweden, is trying to take their investigational drug into a market that is potentially worth $36.11...
Sep 23 2 min Amgen's KRAS Inhibitor Reduces Non-Small Cell Lung Cancer in a Phase I Clinical Trial Amgen is pulling the curtain on full data after releasing small snippets about its keenly watched KRAS inhibitor. The drug, tagged Sotora...
Sep 2 2 min Nestle Acquires Aimmune for $2.6 Billion 💸 Aimmune (AIMT) a biopharmaceutical startup agreed to be acquired by Nestle for $2.6 Billion or $34.50 dollars a share. Before the acquisi...
